HOLUBIAK MYRON Z 4
Accession 0001213900-25-075035
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 4:51 PM ET
Size
31.3 KB
Accession
0001213900-25-075035
Insider Transaction Report
- Award
Warrant to Purchase Common Stock
2025-08-08+22,344→ 22,344 totalExercise: $19.25Exp: 2026-09-27→ Common Stock (22,344 underlying) - Award
Warrant to Purchase Common Stock
2025-08-08+31,373→ 31,373 totalExercise: $28.75Exp: 2026-08-14→ Common Stock (31,373 underlying) - Disposition to Issuer
Warrant to Purchase Common Stock
2025-08-08−31,373→ 0 totalExercise: $28.75Exp: 2025-08-14→ Common Stock (31,373 underlying) - Disposition to Issuer
Warrant to Purchase Common Stock
2025-08-08−22,344→ 0 totalExercise: $19.25Exp: 2025-09-27→ Common Stock (22,344 underlying)
- 14,000
Stock Option (Right to Purchase Common Stock)
Exercise: $9.50Exp: 2034-11-07→ Common Stock (14,000 underlying) - 26,000
Stock Option (Right to Purchase Common Stock)
Exercise: $51.00Exp: 2031-10-11→ Common Stock (26,000 underlying) - 400(indirect: See footnote)
Stock Option (Right to Purchase Common Stock)
Exercise: $50.00Exp: 2031-07-22→ Common Stock (400 underlying) - 7,000
Stock Option (Right to Purchase Common Stock)
Exercise: $16.75Exp: 2029-10-08→ Common Stock (7,000 underlying) - 79,690
Common Stock
- 3,000(indirect: See footnote)
Stock Option (Right to Buy)
Exercise: $9.50Exp: 2034-11-07→ Common Stock (3,000 underlying) - 12,000
Stock Option (Right to Purchase Common Stock)
Exercise: $50.00Exp: 2031-07-22→ Common Stock (12,000 underlying) - 8,000
Stock Option (Right to Purchase Common Stock)
Exercise: $25.25Exp: 2030-10-06→ Common Stock (8,000 underlying) - 6,000
Stock Option (Right to Purchase Common Stock)
Exercise: $40.50Exp: 2028-09-04→ Common Stock (6,000 underlying) - 1,067
Stock Option (Right to Purchase Common Stock)
Exercise: $202.50Exp: 2025-10-01→ Common Stock (1,067 underlying) - 16,000
Stock Option (Right to Purchase Common Stock)
Exercise: $31.25Exp: 2032-10-04→ Common Stock (16,000 underlying) - 1,600
Stock Option (Right to Purchase Common Stock)
Exercise: $86.25Exp: 2027-09-13→ Common Stock (1,600 underlying) - 16,000
Stock Option (Right to Purchase Common Stock)
Exercise: $17.50Exp: 2033-10-10→ Common Stock (16,000 underlying) - 600(indirect: See footnote)
Stock Option (Right to Purchase Common Stock)
Exercise: $51.00Exp: 2031-10-11→ Common Stock (600 underlying)
Footnotes (7)
- [F1]The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately.
- [F2]The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately.
- [F3]The options were granted on November 7, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F4]The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
- [F5]The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F6]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F7]The options are vested in full and exercisable immediately.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Related Parties
1- filerCIK 0001199080
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 4:51 PM ET
- Size
- 31.3 KB